keyword
https://read.qxmd.com/read/38365857/forum-on-immune-digital-twins-a-meeting-report
#21
REVIEW
Reinhard Laubenbacher, Fred Adler, Gary An, Filippo Castiglione, Stephen Eubank, Luis L Fonseca, James Glazier, Tomas Helikar, Marti Jett-Tilton, Denise Kirschner, Paul Macklin, Borna Mehrad, Beth Moore, Virginia Pasour, Ilya Shmulevich, Amber Smith, Isabel Voigt, Thomas E Yankeelov, Tjalf Ziemssen
Medical digital twins are computational models of human biology relevant to a given medical condition, which are tailored to an individual patient, thereby predicting the course of disease and individualized treatments, an important goal of personalized medicine. The immune system, which has a central role in many diseases, is highly heterogeneous between individuals, and thus poses a major challenge for this technology. In February 2023, an international group of experts convened for two days to discuss these challenges related to immune digital twins...
February 16, 2024: NPJ Systems Biology and Applications
https://read.qxmd.com/read/38350907/from-variant-of-uncertain-significance-to-likely-pathogenic-in-two-siblings-with-atypical-rag2-deficiency-a-case-report-and-review-of-the-literature
#22
JOURNAL ARTICLE
Nima Taghizadeh, Soha Mohammadi, Hassan Abolhassani, Sima Shokri, Mohammad Nabavi, Morteza Fallahpour, Mohammad Hassan Bemanian
BACKGROUND: Severe combined immunodeficiencies (SCIDs) are hereditary disorders characterized by impaired T and B cell function, resulting in significant immune system dysfunction. Recombination-activating gene (RAG) mutations account for a substantial proportion of SCID cases. Here, we present two sibling cases of SCID caused by a novel RAG2 gene mutation. CASE PRESENTATION: The index case was an 8-year-old boy who had a history of recurring infections. After a comprehensive immunological workup, the initial diagnosis of agammaglobulinemia was revised to combined immunodeficiency (CID)...
February 13, 2024: BMC Pediatrics
https://read.qxmd.com/read/38339227/immune-assessment-today-optimizing-and-standardizing-efforts-to-monitor-immune-responses-in-cancer-and-beyond
#23
Surya Pandey, Meghan E Cholak, Rishita Yadali, Jeffrey A Sosman, Marie-Pier Tetreault, Deyu Fang, Seth M Pollack, Sacha Gnjatic, Rebecca C Obeng, H Kim Lyerly, Adam M Sonabend, José A Guevara-Patiño, Lisa H Butterfield, Bin Zhang, Holden T Maecker, I Caroline Le Poole
As part of a symposium, current and former directors of Immune Monitoring cores and investigative oncologists presented insights into the past, present and future of immune assessment. Dr. Gnjatic presented a classification of immune monitoring technologies ranging from universally applicable to experimental protocols, while emphasizing the need for assay harmonization. Dr. Obeng discussed physiologic differences among CD8 T cells that align with anti-tumor responses. Dr. Lyerly presented the Soldano Ferrone lecture, commemorating the passionate tumor immunologist who inspired many, and covered a timeline of monitoring technology development and its importance to immuno-oncology...
January 23, 2024: Cancers
https://read.qxmd.com/read/38331990/the-genetic-basis-of-autoimmunity-seen-through-the-lens-of-t-cell-functional-traits
#24
REVIEW
Kaitlyn A Lagattuta, Hannah L Park, Laurie Rumker, Kazuyoshi Ishigaki, Aparna Nathan, Soumya Raychaudhuri
Autoimmune disease heritability is enriched in T cell-specific regulatory regions of the genome. Modern-day T cell datasets now enable association studies between single nucleotide polymorphisms (SNPs) and a myriad of molecular phenotypes, including chromatin accessibility, gene expression, transcriptional programs, T cell antigen receptor (TCR) amino acid usage, and cell state abundances. Such studies have identified hundreds of quantitative trait loci (QTLs) in T cells that colocalize with genetic risk for autoimmune disease...
February 8, 2024: Nature Communications
https://read.qxmd.com/read/38330740/the-autoimmune-rheumatological-presentation-of-common-variable-immunodeficiency-disorders-with-an-overview-of-genetic-testing
#25
REVIEW
Rohan Ameratunga, See-Tarn Woon, Euphemia Leung, Edward Lea, Lydia Chan, James Mehrtens, Hilary J Longhurst, Richard Steele, Klaus Lehnert, Karen Lindsay
Primary immunodeficiency Disorders (PIDS) are rare, mostly monogenetic conditions which can present to a number of specialties. Although infections predominate in most PIDs, some individuals can manifest autoimmune or inflammatory sequelae as their initial clinical presentation. Identifying patients with PIDs can be challenging, as some can present later in life. This is often seen in patients with Common Variable Immunodeficiency Disorders (CVID), where symptoms can begin in the sixth or even seventh decades of life...
January 17, 2024: Seminars in Arthritis and Rheumatism
https://read.qxmd.com/read/38322766/combinatorial-immune-checkpoint-blockade-increases-myocardial-expression-of-nlrp-3-and-secretion-of-h-fabp-nt-pro-bnp-interleukin-1%C3%AE-and-interleukin-6-biochemical-implications-in-cardio-immuno-oncology
#26
JOURNAL ARTICLE
V Quagliariello, M Passariello, I Bisceglia, A Paccone, A Inno, C Maurea, R Rapuano Lembo, L Manna, M Iovine, M L Canale, M Scherillo, P A Ascierto, D Gabrielli, C De Lorenzo, N Maurea
BACKGROUND: Immune checkpoint blockade in monotherapy or combinatorial regimens with chemotherapy or radiotherapy have become an integral part of oncology in recent years. Monoclonal antibodies against CTLA-4 or PD-1 or PDL-1 are the most studied ICIs in randomized clinical trials, however, more recently, an anti-LAG3 (Lymphocyte activation gene-3) antibody, Relatlimab, has been approved by FDA in combination with Nivolumab for metastatic melanoma therapy. Moreover, Atezolizumab is actually under study in association with Ipilimumab for therapy of metastatic lung cancer...
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38291684/joint-espghan-naspghan-guidelines-on-childhood-eosinophilic-gastrointestinal-disorders-beyond-eosinophilic-esophagitis
#27
JOURNAL ARTICLE
Alexandra Papadopoulou, Jorge Amil-Dias, Marcus Karl-Heinz Auth, Mirna Chehade, Margaret H Collins, Sandeep K Gupta, Carolina Gutiérrez-Junquera, Rok Orel, Mario C Vieira, Noam Zevit, Dan Atkins, Albert J Bredenoord, Fatima Carneiro, Evan S Dellon, Nirmala Gonsalves, Calies Menard-Katcher, Sibylle Koletzko, Chris Liacouras, Luba Marderfeld, Salvatore Oliva, Yoshikazu Ohtsuka, Marc E Rothenberg, Alex Strauman, Nikhil Thapar, Guan-Yu Yang, Glenn T Furuta
INTRODUCTION: Eosinophilic gastrointestinal disorders beyond eosinophilic esophagitis (non-EoE EGIDs) are rare chronic inflammatory disorders of the gastrointestinal (GI) tract. Diagnosis is based on clinical symptoms and histologic findings of eosinophilic inflammation after exclusion of a secondary cause or systemic disease. Currently, no guidelines exist for the evaluation of non-EoE EGIDs. Therefore, the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) formed a task force group to provide consensus guidelines for childhood non-EoE EGIDs...
January 2024: Journal of Pediatric Gastroenterology and Nutrition
https://read.qxmd.com/read/38272114/serologic-measurements-for-peanut-allergy-predicting-clinical-severity-is-complex
#28
REVIEW
Alexandra E Conway, David B K Golden, Helen A Brough, Alexandra F Santos, Marcus S Shaker
Allergist-immunologists use serologic peanut allergy testing to maximize test sensitivity and specificity while minimizing cost and inconvenience. Recent advances toward this goal include a better understanding of specific IgE (sIgE) and component testing, epitope-sIgE assays, and basophil activation testing. Predicting reaction severity with serologic testing is challenged by a range of co-factors that influence reaction severity, such as the amount and form of any allergen consumed and comorbid disease. In 2020, the Allergy Immunology Joint Task Force on Practice Parameters recommended Ara h 2-sIgE as the most cost-effective diagnostic test for peanut allergy because of its superior performance, when compared with skin prick testing and serum IgE...
January 24, 2024: Annals of Allergy, Asthma & Immunology
https://read.qxmd.com/read/38235261/analysis-of-questionnaire-survey-to-determine-worldwide-trends-in-prescriptions-of-biologics-for-the-treatment-of-unresponsive-chronic-urticaria
#29
JOURNAL ARTICLE
Christine J Rubeiz, Ricardo Asero, Stephen Betschel, Timothy Craig, Anete Grumach, Michihiro Hide, David Lang, Michael Levin, Hilary Longhurst, Eli Magan, Marcus Maurer, Romi Saini, Gordon Sussman, Elias Toubi, Dinh Nguyen Van, Torsten Zuberier, Jonathan A Bernstein
BACKGROUND: Chronic spontaneous urticaria (CSU) is a common condition treated by allergist/immunologists, but the only FDA-approved biologic medication, omalizumab, may be underutilized globally. OBJECTIVE: This study was performed to determine the global prescription of omalizumab for treatment of CSU by allergists/immunologists. METHODS: Anonymous questionnaire surveys were distributed online to World Allergy Organization (WAO) members worldwide...
January 2024: World Allergy Organization Journal
https://read.qxmd.com/read/38231401/the-inborn-errors-of-immunity-virtual-consultation-system-platform-in-service-for-the-italian-primary-immunodeficiency-network-results-from-the-validation-phase
#30
JOURNAL ARTICLE
Emma Coppola, Mayla Sgrulletti, Manuela Cortesi, Roberta Romano, Emilia Cirillo, Giuliana Giardino, Laura Dotta, Caterina Cancrini, Dario Bruzzese, Raffaele Badolato, Viviana Moschese, Claudio Pignata
PURPOSE: Inborn errors of immunity (IEI) represent a heterogeneous group of rare genetically determined diseases. In some cases, patients present with complex or atypical phenotypes, not fulfilling the accepted diagnostic criteria for IEI and, thus, at high risk of misdiagnosis or diagnostic delay. This study aimed to validate a platform that, through the opinion of immunologist experts, improves the diagnostic process and the level of care of patients with atypical/complex IEI. METHODS: Here, we describe the functioning of the IEI-Virtual Consultation System (VCS), an innovative platform created by the Italian Immunodeficiency Network (IPINet)...
January 17, 2024: Journal of Clinical Immunology
https://read.qxmd.com/read/38193520/a-stepwise-approach-to-the-adult-immunodeficiency-evaluation-for-the-rhinologist
#31
JOURNAL ARTICLE
Timothy M Buckey, John V Bosso
PURPOSE OF REVIEW: Patients with an immunodeficiency may present to their Rhinologist with a history of recurrent, severe, and chronic infections. Therefore, it is essential for the Rhinologist to have a basic understanding of clinically relevant immune deficiencies. RECENT FINDINGS: After describing different types of immunodeficiencies, their presentations, and management strategies, an evaluation algorithm is described. SUMMARY: Through a collaborative approach, Rhinologists and Clinical Immunologists can provide comprehensive medical care to patients with immunodeficiencies...
February 1, 2024: Current Opinion in Otolaryngology & Head and Neck Surgery
https://read.qxmd.com/read/38182128/chronic-neutropenia-in-childhood-experience-of-a-tertiary-center
#32
JOURNAL ARTICLE
Letícia Matushita, Elvis Terci Valera, Davi Casale Aragon, Carlos Alberto Scridelli, Persio Roxo-Junior, Luciana Martins de Carvalho
OBJECTIVE: To assess the prevalence of chronic neutropenia (CN) and the clinical profile of patients with CN aged up to 18 years, followed in the pediatric hematology, rheumatology, or immunology outpatient clinic of a tertiary medical center from May 1, 2018, to 30 April 2019. METHODS: Retrospective observational study carried out by collecting data from the patient's medical charts. CN was defined as absolute neutrophil count (ANC) below 1.5 × 109 /L lasting over three months...
January 2, 2024: Jornal de Pediatria
https://read.qxmd.com/read/38164871/research-trends-of-janus-kinase-inhibitors-a-bibliometric-and-visualized-study-from-2012-to-2023
#33
REVIEW
H-C Chang, R-Y Tsai, C-Y Lee, Y-H Kuan, W-C Liao, S-J Chen, S-Y Gau
OBJECTIVE: Janus Kinase (JAK) inhibitors have been extensively evaluated for their potential in the management of various diseases. Despite previous research on this topic, there is a lack of bibliometric analysis that summarizes research trends on JAK inhibitors. This study aims to provide a comprehensive overview of the top 100 most frequently cited studies on JAK inhibitors over the last ten years. MATERIALS AND METHODS: The Web of Science database was used to screen and extract relevant studies on JAK inhibitors...
December 2023: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/38141459/production-and-characterization-of-anti-porcine-cxcl10-monoclonal-antibodies
#34
JOURNAL ARTICLE
Taylor Hailstock, Chaohui Dai, Jovan Aquino, Kristen E Walker, Shannon Chick, Jean N Manirarora, Raksha Suresh, Veerupaxagouda Patil, Gourapura J Renukaradhya, Yvonne B Sullivan, Joanna LaBresh, Joan K Lunney
Research on C-X-C motif chemokine ligand 10 (CXCL10) has been widely reported for humans and select animal species, yet immune reagents are limited for pig chemokines. Our goal is to provide veterinary immunologists and the biomedical community with new commercial immune reagents and standardized assays. Recombinant porcine CXCL10 (rPoCXCL10) protein was produced by yeast expression and used to generate a panel of α CXCL10 monoclonal antibodies (mAbs). All mAbs were assessed for cross-inhibition and reactivity to orthologous yeast expressed CXCL10 proteins...
February 2024: Cytokine
https://read.qxmd.com/read/38125294/hong-kong-macau-severe-hives-and-angioedema-referral-pathway
#35
JOURNAL ARTICLE
Philip H Li, Elaine Y L Au, Si-Leong Cheong, Ling Chung, Ka I Fan, Marco H K Ho, Agnes S Y Leung, Martin M H Chung, Jane C Y Wong, Ricardo Coelho
BACKGROUND: Urticaria (defined as the presence of hives, angioedema, or both) can be caused by a variety of etiologies ranging from more common conditions such as chronic spontaneous urticaria (CSU) to rarer conditions such as hereditary angioedema (HAE). Specialist referral may be necessary in cases of severe urticaria or HAE, but access to specialist services remains limited in certain regions, such as the Greater Bay Area (GBA) of China. To address this, the Hong Kong-Macau Severe Hives and Angioedema Referral Pathway (SHARP) was initiated by the Hong Kong Institute of Allergy and Macau Society of Dermatology to promote multidisciplinary collaboration and regional exchange of expertise in the diagnosis and management of severe urticaria...
2023: Front Allergy
https://read.qxmd.com/read/38116677/deep-ultraviolet-266%C3%A2-nm-laser-excitation-for-flow-cytometry
#36
JOURNAL ARTICLE
William Telford
High dimensional flow cytometry relies on multiple laser sources to excite the wide variety of fluorochromes now available for immunophenotyping. Ultraviolet lasers (usually solid state 355 nm) are a critical part of this as they excite the BD Horizon™ Brilliant Ultraviolet (BUV) series of polymer fluorochromes. The BUV dyes have increased the number of simultaneous fluorochromes available for practical high-dimensional analysis to greater than 40 for spectral cytometry. Immunologists are now seeking to increase this number, requiring both novel fluorochromes and additional laser wavelengths...
December 20, 2023: Cytometry. Part A: the Journal of the International Society for Analytical Cytology
https://read.qxmd.com/read/38110863/pepmatch-a-tool-to-identify-short-peptide-sequence-matches-in-large-sets-of-proteins
#37
JOURNAL ARTICLE
Daniel Marrama, William D Chronister, Luise Westernberg, Randi Vita, Zeynep Koşaloğlu-Yalçın, Alessandro Sette, Morten Nielsen, Jason A Greenbaum, Bjoern Peters
BACKGROUND: Numerous tools exist for biological sequence comparisons and search. One case of particular interest for immunologists is finding matches for linear peptide T cell epitopes, typically between 8 and 15 residues in length, in a large set of protein sequences. Both to find exact matches or matches that account for residue substitutions. The utility of such tools is critical in applications ranging from identifying conservation across viral epitopes, identifying putative epitope targets for allergens, and finding matches for cancer-associated neoepitopes to examine the role of tolerance in tumor recognition...
December 18, 2023: BMC Bioinformatics
https://read.qxmd.com/read/38044226/intractable-diarrhea-in-infancy-and-molecular-analysis-we-are-beyond-the-tip-of-the-iceberg
#38
JOURNAL ARTICLE
A Diamanti, C M Trovato, P Gandullia, A Lezo, M I Spagnuolo, G Bolasco, T Capriati, L Lacitignola, L Norsa, P Francalanci, A Novelli
BACKGROUND: Intractable diarrhea (ID) could be defined as a syndrome of severe chronic diarrhea associated with malnutrition not easily resolved by conventional management. AIMS: To provide an overview on etiology and management of ID patients in Italy in the last 12 years. METHODS: The members of Italian Society for Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP) enrolled all ID patients seen between January 1, 2011 and December 31, 2022...
April 2024: Digestive and Liver Disease
https://read.qxmd.com/read/38023329/enhanced-annotation-of-cd45ra-to-distinguish-t-cell-subsets-in-single-cell-rna-seq-via-machine-learning
#39
JOURNAL ARTICLE
Ran Ran, Douglas K Brubaker
MOTIVATION: T cell heterogeneity presents a challenge for accurate cell identification, understanding their inherent plasticity, and characterizing their critical role in adaptive immunity. Immunologists have traditionally employed techniques such as flow cytometry to identify T cell subtypes based on a well-established set of surface protein markers. With the advent of single-cell RNA sequencing (scRNA-seq), researchers can now investigate the gene expression profiles of these surface proteins at the single-cell level...
2023: Bioinform Adv
https://read.qxmd.com/read/38022498/too-much-of-a-good-thing-a-review-of-primary-immune-regulatory-disorders
#40
REVIEW
Christo Tsilifis, Mary A Slatter, Andrew R Gennery
Primary immune regulatory disorders (PIRDs) are inborn errors of immunity caused by a loss in the regulatory mechanism of the inflammatory or immune response, leading to impaired immunological tolerance or an exuberant inflammatory response to various stimuli due to loss or gain of function mutations. Whilst PIRDs may feature susceptibility to recurrent, severe, or opportunistic infection in their phenotype, this group of syndromes has broadened the spectrum of disease caused by defects in immunity-related genes to include autoimmunity, autoinflammation, lymphoproliferation, malignancy, and allergy; increasing focus on PIRDs has thus redefined the classical 'primary immunodeficiency' as one aspect of an overarching group of inborn errors of immunity...
2023: Frontiers in Immunology
keyword
keyword
167687
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.